|
2025
|
Invention
|
Benzimidazole and benzimidazolone based protac compounds for the targeted degradation of leucine ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
2024
|
Invention
|
Rapidly accelerating fibrosarcoma protein degrading compounds and associated methods of use.
Bif... |
|
|
Invention
|
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor deg... |
|
|
Invention
|
Compounds and methods for the targeted degradation of androgen receptor.
The present disclosure ... |
|
|
Invention
|
Synthesis of leucine-rich repeat kinase 2 modulators. Provided are methods for synthesizing compo... |
|
|
Invention
|
Use of androgen receptor degrader for the treatment of spinal and bulbar muscular atrophy.
This ... |
|
|
Invention
|
Use of androgen receptor degrader for the treatment of spinal and bulbar muscular atrophy. This d... |
|
|
Invention
|
Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use.
Provid... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
Invention
|
Compounds and methods for the targeted degradation of bromodomain-containing proteins.
The prese... |
|
|
Invention
|
Crystalline and amorphous forms of a compound for the targeted degradation of estrogen receptor. ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer Medical informational services, including... |
|
|
Invention
|
Vepdegestrant dosage regimen in cyp3a-inducer treatment in cancer. The invention relates to a met... |
|
|
Invention
|
Indazole based compounds and associated methods of use.
Bifunctional compounds, which find utili... |
|
|
Invention
|
Dgk targeting compounds and uses thereof. e.ge.g., cancer) and viral infections. |
|
|
Invention
|
Hpk1 targeting compounds and uses thereof. Described herein are compounds that modulate hematopoi... |
|
|
Invention
|
Compounds useful in the treatment of kras mediated disorders. e.g.e.g., compounds of Formula (I))... |
|
|
Invention
|
Compounds and methods for the targeted degradation of androgen receptor.
This disclosure pertain... |
|
|
Invention
|
Compounds and methods for the targeted degradation of androgen receptor. This disclosure pertains... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Combinations of estrogen receptor degraders and cdk7 inhibitors for the treatment of cancer. Disc... |
|
|
Invention
|
Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, a... |
|
|
Invention
|
Solid oral dosage forms of estrogen receptor degraders. Disclosed herein are solid oral dosage fo... |
|
|
Invention
|
Combinations of estrogen receptor degraders and akt inhibitors. Disclosed herein are methods for ... |
|
|
Invention
|
Bavdegalutamide for treating prostate cancer without ar l702h mutation. This disclosure pertains ... |
|
|
Invention
|
Use of an androgen receptor degrader protac for the treatment of prostate cancer. The present app... |
|
|
Invention
|
Egfr proteolysis targeting chimeric molecules and associated methods of use.
The present inventi... |
|
|
Invention
|
Crystalline forms of a compound for the targeted degradation of the androgen receptor.
The prese... |
|
|
Invention
|
Crystalline forms of a compound for the targeted degradation of the androgen receptor. The presen... |
|
|
Invention
|
Dosage regimens of estrogen receptor degraders. Disclosed herein are methods for treating cancer ... |
|
|
Invention
|
Modulators of bcl6 proteolysis and associated methods of use.
Bifunctional compounds, which find... |
|
|
Invention
|
Dosage regimens of estrogen receptor degraders in combination with an mtor inhibitor. Disclosed h... |
|
|
Invention
|
Cereblon-based kras degrading protacs and uses related thereto.
Provided herein are compounds th... |
|
|
Invention
|
Cereblon-based kras degrading protacs ans uses related thereto. Provided herein are compounds tha... |
|
|
Invention
|
Pharmaceutical formulations of an androgen receptor-targeting protein degrader. The present discl... |
|
|
Invention
|
Modulators of bcl6 proteolysis and associated methods of use.
This application pertains to the u... |
|
|
Invention
|
Modulators of bcl6 proteolysis and associated methods of use. This application pertains to the us... |
|
2023
|
Invention
|
Method of treating breast cancer. The invention relates to a method for treating cancer in a subj... |
|
|
Invention
|
Casitas b-lineage lymphoma protooncogene b (cbl-b) degrading compounds and associated methods of ... |
|
|
Invention
|
Selective modulators of mutant lrrk2 proteolysis and associated methods of use.
Bifunctional com... |
|
|
Invention
|
Rapid accelerated fibrosarcoma (raf) degrading compounds and associated methods of use.
or pharm... |
|
|
Invention
|
Modulators of bcl6 proteolysis and associated methods of use.
This disclosure pertains to bifunc... |
|
|
Invention
|
Tau-protein targeting compounds and associated methods of use.
The present disclosure relates to... |
|
|
Invention
|
Imide-based modulators of proteolysis and associated methods of use.
The description relates to ... |
|
|
Invention
|
Bavdegalutamide and combinations thereof for use in treating prostate cancer.
This disclosure pe... |
|
|
Invention
|
Compounds and methods for the targeted degradation of kras.
Bifunctional compounds, which find u... |
|
2022
|
Invention
|
Brm targeting compounds and associated methods of use.
The present disclosure relates to bifunct... |
|
|
Invention
|
Brm degrading compounds and associated methods of use.
The present disclosure relates to bifunct... |
|
|
G/S
|
Pharmaceutical preparations for use in treating oncology, immunology, and central nervous system ... |
|
|
G/S
|
Pharmaceutical preparations for use in treating oncology,
immunology, and inflammatory diseases,... |
|
2021
|
G/S
|
Agricultural products development |
|
|
G/S
|
Bi-functional small molecules that mediate targeted protein degradation through the ubiquitin pro... |
|
|
G/S
|
Pharmaceutical preparations for use in treating oncology, immunology, and inflammatory diseases, ... |
|
2020
|
G/S
|
Pharmaceutical products development of new small molecules aimed at degrading disease-causing cel... |
